Comway Capital

Comway Capital Group is a private equity and venture capital firm established in 2000 and located in Shanghai, China. The firm specializes in investing in emerging growth and growth capital, focusing on sectors such as biology, technology, media, telecommunications, advanced manufacturing, new materials, new energy, consumer goods, and modern services. Comway Capital aims to support companies based in China and has invested in over 16 enterprises, amounting to a total of RMB 3 billion since its inception.

Ji Li Ph.D

Managing Partner

Liying Yang

Vice President

Li Zhai

CEO and Managing Partner

6 past transactions

SAFE Pharmaceutical

Angel Round in 2016
SAFE Pharmaceutical, officially known as Beijing Saifu Medical Research Institute Co., Ltd., operates as a Contract Research Organization (CRO) specializing in pharmaceutical research and development services. The company collaborates with esteemed institutions such as the Shanghai Institute of Materia Medica and the National Drug Safety Evaluation and Research Center, leveraging their expertise to enhance its operational capabilities. With a core team comprised of experienced researchers from prestigious scientific organizations, SAFE Pharmaceutical offers comprehensive services that include R&D consulting, toxicology evaluations, and clinical trial design. This integrated approach allows pharmaceutical developers to efficiently advance their product research and development initiatives, supported by strong technical expertise and management experience in drug development and GLP compliance.

Chery New Energy

Series B in 2016
Developer and manufacturer of new energy vehicle. The company's products based on cutting-edge technologies for clean energy vehicles, including main models such as miniature pure electric vehicles, mid-level pure electric vehicles, miniature electric buses, enabling users with clean energy traveling choices.

Chery Automobile

Venture Round in 2007
Chery Automobile
Jiangsu Nata Opto-electronic Material Co Ltd develops, manufactures and sells photoelectric new material high-purity metal organic source. The company's main products include trimethyl gallium, trimethyl indium, and trimethyl aluminum.

Deosen Biochemical

Venture Round in 2000
Deosen Biochemical, established in 2005 and originating from Shandong Zhongxuan Corporation Ltd., specializes in the research, development, production, and sales of hydrocolloids and stabilizers, with a focus on xanthan gum. The company's products serve diverse industries, including food, personal care, medical, and industrial sectors, where they are utilized as food additives, thickening agents, and stabilizers. Deosen's production base is located in Ordos City, Inner Mongolia, while its sales department operates from Zibo City, Shandong Province.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.